4,7-Dichloro benzothien-2-yl sulfonylaminomethyl boronic acid: first boronic acid-derived beta-lactamase inhibitor with class A, C, and D activity.
Qiang Tan, Aimie M Ogawa, Ronald E Painter, Young-Whan Park, Katherine Young, Frank P DiNinno, Qiang Tan, Aimie M. Ogawa, Ronald E. Painter, Young-Whan Park, Katherine Young, Frank P. DiNinno
Index: Bioorg. Med. Chem. Lett. 20 , 2622-4, (2010)
Full Text: HTML
Abstract
4,7-Dichloro-1-benzothien-2-yl sulfonylaminomethyl boronic acid (DSABA, Compound I) was discovered as the first boronic acid-based class D beta-lactamase inhibitor. It exhibited an IC(50) of 5.6 microM against OXA-40. The compound also inhibited class A and C beta-lactamases with sub to low microM IC(50), and synergized with imipenem against Acinetobacter baumannii.Copyright 2010 Elsevier Ltd. All rights reserved.
Related Compounds
Related Articles:
2014-11-01
[J. Antibiot. 67(11) , 763-9, (2014)]
2015-03-01
[J. Gastroenterol. Hepatol. 30 Suppl 1 , 60-5, (2015)]
2013-04-21
[Dalton Trans. 42(15) , 5573-86, (2013)]
1997-01-01
[Talanta 44(1) , 97-103, (1997)]
First bite syndrome: Our experience with intraparotid injections with botulinum toxin type A.
2016-01-01
[Laryngoscope 126 , 104-7, (2016)]